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Photodynamic therapy (PDT) requires a photosensitising drug, light and oxygen. While it is known that the haemoglobin oxygen
saturation (HbSat) can be altered by PDT, little has been done to correlate this with microvascular changes and the final biological
effect. This report describes such studies on the normal liver of rats sensitised with aluminium disulphonated phthalocyanine. In total,
50J of light at 670nm, continuous or fractionated at 25 or 100mW, was applied with a single laser fibre touching the liver surface.
HbSat was monitored continuously 1.5–5.0mm from the laser fibre using visible light reflectance spectroscopy (VLRS). Vascular
shutdown was assessed by fluorescein angiography 2 40min after light delivery. Necrosis was measured at post mortem 3 days after
PDT. In all treatment groups at a 1.5mm separation, HbSat fell to zero with little recovery after light delivery. At 2.5mm, HbSat also
decreased during light delivery, except with fractionated light, but then recovered. The greatest recovery of fluorescein perfusion after
PDT was seen using 25mW, suggesting an ischaemia/reperfusion injury. Necrosis was more extensive after low power and
fractionated light than with 100mW, continuous illumination. We conclude that VLRS is a useful technique for monitoring HbSat,
although the correlation between HbSat, fluorescein exclusion and necrosis varied markedly with the light delivery regimen used.
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Photodynamic therapy (PDT) is a treatment for a range of
malignant and benign conditions using light-activated photosen-
sitising drugs in the presence of molecular oxygen (Dougherty et al,
1998). PDT causes tissue damage by a combination of processes
involving the production of reactive oxygen species (in particular
singlet oxygen). Studies in experimental tumours suggest that
there are three main mechanisms of tissue damage. Firstly, PDT
may damage cells directly causing apoptosis and/or necrosis (Luo
and Kessel, 1997); secondly, PDT may cause blood flow stasis by
vessel constriction, platelet aggregation and/or fibrin plugging.
Shortly after light delivery a third process has been noted, where
vasoactive lipids, fluid and macromolecules leak from the treated
cells, inducing oedema and an inflammatory response (Fingar et al,
1992). The response depends on the drug being used, the drug light
interval (DLI), the light dose and light power as well as the nature
of the tissue being treated and the availability of oxygen (Ochsner,
1997).
Since the cytotoxic effect depends on oxygen, monitoring of
tissue oxygenation both during and after PDT is important for
understanding the basic physiological mechanisms and dosimetry
of PDT (Fingar et al, 1992). Both photochemical consumption of
oxygen and microvascular shutdown can lead to depletion of
molecular oxygen during PDT, limiting the biological effect
(Henderson and Fingar, 1987). Photochemical consumption of
molecular oxygen can occur through the oxidation of tissue
substrate biomolecules by reactive oxygen intermediates generated
via Type II and Type I mechanisms (Bonnett, 1999). It has been
suggested that tissue oxygenation can be reduced by these
processes to levels insufficient for any further PDT effect to occur
(Sitnik et al, 1998; Henderson et al, 2000).
A range of methods is available for monitoring oxygenation
changes induced by PDT. Tissue partial pressure of oxygen (pO2)
has been measured using oxygen microelectrodes to investigate
PDT-induced changes in vivo with a range of photosensitising
agents including porfimer sodium, 5-aminolaevulinic acid-induced
protoporphyrin IX (ALA) and benzoporphyrin mono-acid
(Curnow et al, 2000; Henderson et al, 2000; Pogue et al, 2001).
However, microelectrodes have poor sensitivity at very low levels
of pO2 and the depth of tissue interrogated has been estimated to
be only 15–20mM (Ince and Sinaasappel, 1999). Electron
paramagnetic resonance oximetry has also been used to follow
long-term changes in tumour tissue oxygenation in response to
benzoporpyhrin mono-acid and ALA PDT (Pogue et al, 2002). We
have previously used PdTCPP (palladium meso-tetracarboxylphe-
nyl porphine) as a systemically administered oxygen probe and
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tor microvascular changes in oxygen levels in response to PDT
with ALA (McIlroy et al, 1998).
Noninvasive, optical techniques based on reflectance spectro-
scopy for the measurement of the oxy- to deoxyhaemoglobin ratio
offer an alternative approach. In this study, the application of a
new reflectance spectroscopy monitoring system with a restricted
wavelength range has been investigated, and is referred to
hereafter as the visible light spectrometer (VLRS). The VLRS uses
a thin fibre-optic probe that reflectance can be placed at
preselected sites on the tissue surface to provide a continuous
real-time recording throughout the treatment. This study describes
its use for monitoring PDT-induced changes in haemoglobin
oxygen saturation (HbSat) in real time and correlating the results
with the final biological effect. The importance of vascular effects
under the same treatment conditions was assessed using
fluorescein angiography.
Fluorescein angiography is an established in vivo technique for
assessing vascular shutdown and has been used to monitor PDT
effects (Bellnier et al, 1995). Recovery of perfusion after episodes
of temporary ischaemia is known to be a potent instigator of the
inflammatory response and is responsible for severe tissue damage
in a variety of common conditions such as stroke, myocardial
infarction and organ transplant rejection (Zimmerman and
Granger, 1994). Ischaemia is associated with the production of
xanthine oxidase (XO) while, in parallel, hypoxanthine accumu-
lates because of the breakdown of adenosine triphosphate (ATP)
(Zimmerman and Granger, 1994). When oxygen is reintroduced, it
enables XO to induce the formation of xanthine from hypox-
anthine, resulting in the release of reactive oxygen species,
primarily superoxide anions and hydroxyl radicals. There is
growing evidence from experiments with other photosensitisers
such as porfimer sodium and ALA that reperfusion ischaemia
injury may be important (Curnow and Bown, 2002; Korbelik et al,
2003).
MATERIALS AND METHODS
Animal model
Normal, female Wistar rats (180–220g, Harlan, Oxon, UK) were
used for all experiments. The normal liver was chosen as a suitable
model for this study as it is a convenient size in 200g rats and its
homogeneity makes it straightforward to observe and make
measurements on the surface during and after PDT, as in our
previous dose response studies using phthalocyanine sensitisation
(Bown et al, 1986). All procedures were performed under general
anaesthesia with inhaled Halothane (ICI, Cheshire, UK). Analgesia
was administered subcutaneously following surgery (Buprenor-
phine hydrochloride, Reckitt and Colmann, Hull, UK). All animal
experiments were carried out under the authority of project and
personal licences granted by the Home Office.
Photosensitiser
Aluminium disulphonated phthalocyanine (AlS2Pc) powder (Prof
D Phillips, Imperial College London) was dissolved in physiolo-
gical strength, phosphate-buffered saline (PBS) at a concentration
of1mgml
 1 and was administered by tail vein injection at a dose
of 1mgkg
 1 body weight. The disulphonated derivative was
chosen for this study since it has been shown to be the most
effective for PDT (Chatlani et al, 1991).
Photodynamic therapy studies
Rats were sensitised 1, 3 or 24h prior to PDT. The liver was
exposed at laparotomy, and a 400mM plane cleaved fibre from a
670nm Diode laser (Hamamatsu Photonics K.K., Hamamatsu,
Japan) was positioned by means of a micromanipulator so that it
was just touching the surface of the organ. The key advantages of
this method of surface irradiation were firstly that we could
position the fibre-optic probe on the surface at precise distances
from the laser fibre and, secondly that it produced well-defined
lesions, which enabled a quantitative comparison between the
monitoring results and PDT-induced damage to be made.
Although the light fluence rate where the laser fibre touched the
tissue was high, no thermal effect was observed in the light-only
control groups. In all cases, the total light dose delivered was 50J.
The illumination regimens investigated were: low power (25mW)
continuous, high power (100mW) continuous and high power
(100mW) fractionated (5 10J, with 60s between each fraction).
Laser-only and drug-only controls were also carried out. There was
a minimum of three animals in each group. All animals were
recovered following surgery and killed 3 days later. The minimum
(a) and maximum (b) perpendicular diameters of the nearly
circular lesions were measured and the surface area was calculated
using the formula pab/4. For comparison with the macroscopic
findings, representative tissue specimens were fixed in 4%
formalin, wax embedded, sectioned and stained with haematoxylin
and eosin for examination by light microscopy.
Monitoring tissue oxygen saturation
Continuous real-time recording of in vivo HbSat levels was carried
out during and after PDT by means of a PMA-11 spectrograph
(Model C7473-36, Hamamatsu Photonics K.K., Hamamatsu,
Japan). The PMA-11 is a Czerny-Turner type spectrograph that
has a 256 128 pixel back-thinned CCD linear image sensor,
cooled to  151C. The system measures simultaneously over a
wavelength range of 485–635nm and a spectral resolution of
0.5nm that has been calibrated using the bright-line spectrum of a
Hg–Ar lamp at 546.07, 576.96 and 579.07nm. Spectra were
collected at 20Hz, and 10 spectra were averaged to improve the
signal to noise ratio. The experimental arrangement of the VLRS
system is shown in Figure 1.
The fibre-optic probe (Avantes BV, Eerbeek, NL) was a
bifurcated, hexagonally arranged fibre bundle consisting of seven
fibres each with a 200mM core encased in a 1.5mm diameter
stainless steel tip. The six outer light fibres were coupled to a
Tungsten Halogen lamp (Model 77501, Oriel Scientific Ltd, Surrey,
UK) that was filtered with a green glass filter (Scott BG 18) and a
glass heat-absorbing filter (Schott KG3). The use of the red-
absorbing green filter minimised any PDT effect induced by the
lamp as confirmed in control studies. The central sensing fibre was
coupled to the PMA-11 spectrograph via a standard SMA905
connector. The PMA-11 analysis software (Department of Medical
Physics and Bioengineering, University College London, London,
UK) calculates the changes in oxyhaemoglobin (HbO) and
deoxyhaemoglobin (Hb) in mmoll
 1 from changes in the spectral
Liver
670 nm
Diode laser
VLRS sensor
probe
PDT fibre
ø 400 m
PC
Cooled CCD
Spectrometer
Tungsten 
halogen 
lamp
Figure 1 Experimental arrangement for the visible light reflectance
spectrometer (VLRS) with the PDT fibre and the VLRS probe positioned
on the surface of the liver at a fixed centre-to-centre separation.
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sattenuation derived from the light reflectance spectra acquired by
the spectrometer over its 485–635nm detection range. From these
values, we derived the total haemoglobin (HbT) in mmoll
 1 as the
sum of the HbO and Hb, and the HbSat (expressed as a
percentage), which is HbO divided by HbT. The software of the
VLRS uses a least-squares fitting algorithm applied over a reduced
wavelength range where the wavelength dependence of the
differential path length is approximately flat and the depth of
penetration into the tissue is approximately constant.
Prior to PDT, the fibre-optic probe was placed on the liver
surface at separations of 1.5, 2.5, 3.5 or 5.0mm from the laser fibre,
so that we could monitor tissue sites to which different light doses
were delivered. In each case, HbSat was measured for 5min prior
to light delivery to obtain a starting saturation value. Since the
VLRS was insensitive to the PDT laser wavelength, we were able to
record readings during PDT. The total time of monitoring from the
time the laser was switched on was typically 45min including post-
PDT monitoring. There was a minimum of three animals at each
separation between the laser fibre and the VLRS probe and in each
treatment group.
Fluorescein angiography
To limit fluorescein leakage into the interstitium, the higher
molecular weight derivative, fluorescein isothiocyanate dextran
(FITC-Dextran), was used in these studies. This substance is
confined to the vasculature, and imaging of the fluorescence
allowed us to map which areas are not perfused at various times
after light delivery.
Immediately after PDT, 100mgkg
 1 bodyweight of FITC-
Dextran, (150000MW conjugate, Fluka Chemicals Ltd, Dorset,
UK) dissolved in physiological strength PBS was injected via the
tail vein. The fluorescein was excited using a 3mW light emitting
diode (LED) with peak output at 470nm (Roithner Lasertechnik,
Vienna, Austria) that was directed into a liquid light guide for
illumination of the target area. A short focal length lens was
connected to the end of the light guide together with a 470720nm
band pass filter and coupled to a 50/50 C-mounted plate beam
splitter (Edmund Optics Ltd, York, UK) so that the excitation
beam was perpendicular to the tissue surface. The fluorescence was
imaged through the beam splitter mirror at 530nm (720nm)
using a band pass filter (Omega Optical Inc., VT, USA) and a long
pass filter (Schott OG515) with a sensitive PC-controlled cooled
CCD camera (Wright Instruments Ltd, Enfield, UK) capturing a
field of 600 400 pixels fitted with a video lens capable of  0.75
magnification (Infinimite video lens, Edmund Optics Ltd, York,
UK). Grey scale fluorescence images (o1s integration time) were
captured every 2min for 40min after PDT. These images revealed
an area of decreased fluorescence centred on the laser fibre. Using
Image Toll analysis software (San Antonio, USA), the mean radius
of these almost circular zones of fluorescein exclusion was
calculated. Control animals received either photosensitiser alone
or light alone.
Statistical analysis
A minimum of three animals was used in each of the PDT and
fluorescein angiography groups. Statistical analysis of means in
each PDT treatment group was conducted using nonparametric
one-way ANOVA. Error bars on all the figures were determined by
the standard deviation of the mean.
RESULTS
Oxygen saturation measurements
The VLRS simultaneously monitors HbO, Hb, HbT and HbSat.
Figure 2A depicts representative data collected from a single
animal with the VLRS probe 1.5mm from the PDT fibre and
illustrates the stability of the system over the 45min monitoring
period used. Figure 2B shows spectra of remitted intensity taken
from the same animal before PDT (time 0min) where HbO
predominates, and after PDT (time 15min) where Hb predomi-
nates; in the earlier case, the attenuation due to absorption by HbO
is clearly evident close to 540 and 580nm. The main aim of this
study was to monitor oxygen saturation, so only the oxygenation
results are shown for the other animals. The baseline HbSat in liver
prior to PDT was 6175% (range 49–71%, n¼40 animals). All
animals were treated with a total light dose of 50J. The effect of
varying the light delivery regimen was studied using a drug-light
interval of 24h as our previous work and that of others using
AlSPc in normal liver (Bown et al, 1986), and small rodent tumours
(Tralau et al, 1987; Moan and Anholt, 1990) had shown a more
homogeneous drug fluorescence distribution at this DLI compared
with shorter times. Drug light intervals of 1 and 3h were studied
with a fixed light delivery regimen of 100mW, continuous. The
results are shown in Figure 3A–E. Control studies with light but
without sensitiser showed no changes in HbSat.
In all cases, the HbSat dropped to zero at the 1.5mm separation
between laser fibre and VLRS probe and did not change at the
5.0mm separation. At the 1.5mm separation, the reduction was
most rapid using high-power (100mW), continuous illumination.
At low power (25mW), there was a slower rate of decrease,
Time (min)
−5 0 5 1 01 52 02 53 03 54 0
H
a
e
m
o
g
l
o
b
i
n
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(

m
o
l
 
l
−
1
)
0
100
200
300
400
M
e
a
n
 
H
b
 
s
a
t
u
r
a
t
i
o
n
 
(
%
)
0
20
40
60
80
100
HbT (mol l
−1)
HbO (mol l
−1)
Hb (mol l
−1)
HbSat (%)
Wavelength (nm)
500 520 540 560 580 600 620 640
I
n
t
e
n
s
i
t
y
 
(
a
.
u
.
)
0
500
1000
1500
2000
2500
Before PDT
After PDT
A
B
Figure 2 Data collected from a single animal treated (100mW, 50J)
24h after sensitisation with a 1.5mm fibre to VLRS probe separation
showing (A) HbT: total haemoglobin. HbO: oxyhaemoglobin. Hb:
deoxyhaemoglobin. HbSat (%): percentage haemoglobin oxygen saturation;
(B) Spectra of remitted intensity before (time 0min) and after PDT (time
15min) in the same animal.
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salthough the drop was just as large by the end of light delivery. In
all cases, there was some drop at the 2.5mm separation except for
the fractionated light regimen. The only significant falls in HbSat
at 3.5mm were seen with the short DLIs (1 and 3h). A summary of
the key changes in HbSat at 2.5 and 3.5mm are shown in Table 1.
The minimum value of HbSat, the recovery value of HbSat post-
PDT for each treatment regimen and the time taken to reach those
values from when the laser was switched on are shown.
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Figure 3 Visible light reflectance spectrometer measurements of HbSat (%) in the normal rat liver before, during and after PDT. Each point represents the
mean (with the standard deviation of the mean) from a minimum of three animals. Measurements were made at separations of 1.5, 2.5, 3.5 and 5.0 mm
between the VLRS probe and the PDT fibre (one separation per animal). The shaded areas indicate the time when the laser was switched on. All animals
were sensitised with 1mgkg
 1 body weight AlS2Pc and received a total light dose of 50J at 670nm. (A) High-power continuous treatment (100mW) with
1h DLI. (B) High-power continuous treatment (100mW) with 3h DLI. (C) High-power continuous treatment (100mW) with 24h DLI. (D) Low-power
continuous treatment (25mW) with 24h DLI. (E) High-power treatment with fractionation (100mW, 5 10J, 60s between fractions) with 24h DLI.
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Fluorescein angiography was used to quantify post-PDT changes
in microvascular perfusion in the treated portion of the liver, using
the same irradiation regimen as in the oxygen-monitoring
experiments. In control animals (without light), the green
fluorescence was distributed evenly in the liver. In PDT-treated
animals, fluorescein was excluded from an area centred on the
laser fibre (Figure 4). The extent and duration of the fluorescein
exclusion depended on the treatment parameters. Very little
reperfusion was evident with a 1-h DLI, but with a DLI of 24h and
low-power irradiation, reperfusion was documented in almost 50%
of the area initially seen to be ischaemic. The mean radius of each
fluorescein exclusion zone 2 and 40min after PDT is shown in
Table 1.
Photodynamic therapy effects
The lesions produced in the liver 3 days after PDT were well
defined and easy to measure. Histological examination of
representative sections confirmed that macroscopic measurements
correlated well with the extent of necrosis seen microscopically.
Using continuous irradiation at 25mW, the surface area of
necrosis was approximately 60% larger than using 100mW and
15% greater than with fractionated irradiation (Po0.0001,
Student’s t-test). The results are shown in Table 1.
DISCUSSION
This study set out to assess a new device for monitoring HbSat
during PDT and to look at the possibility of using these
oxygenation measurements for predicting the extent of PDT
necrosis. Spatially resolved HbSat measurements were carried out
using a VLRS system, which proved simple and reliable to use, and
provided reproducible measurements in groups of animals treated
with a range of different light delivery regimens. The liver HbSat
measured by the VLRS in control animals and prior to PDT was
remarkably constant at 6175%, which is similar to the published
value of 5978% measured transcutaneously with near infrared
(NIR) spectroscopy in children (Weiss et al, 2002). Although NIR
spectroscopy can provide the same information as the VLRS
technique, the spatial resolution of NIR sensing is poorer owing to
the much weaker haemoglobin absorption in the NIR wavelength
range. For optical monitoring during PDT, there is also the
problem of interference from the PDT laser wavelength to
consider. However, when using a 670nm laser, the scattered light
is beyond the VLRS detection range and we were therefore able to
record data throughout treatment.
Table 1 Key haemoglobin saturation (HbSat) measurements 2.5 and 3.5mm from the PDT fibre, and the dimensions of the fluorescein exclusion zones 2
and 40min after PDT and of the zones of necrosis 3 days after PDT
Treatment
conditions
(50J, 670 nm)
DLI
(h)
% HbSat
minimum at
2.5mm (time
from laser on)
% HbSat
recovery
value at
2.5mm (time
from laser on)
% HbSat
minimum at
3.5mm
(time from
laser on)
% HbSat
recovery
value at
3.5mm (time
from laser on)
Radius of
fluorescein
exclusion
2min post-
PDT (mm)
Radius of
fluorescein
exclusion,
40min post-
PDT (mm) (%
decrease vs
2min)
Maximum
radius of
necrosis at 3
days (mm)
Area of
necrosis at 3
days (mm
2)
100mW
continuous
1 12 (5min) 31 (15min) 42 (15min) 62 (25min) 3.470.3 3.370.4 (3%) 4.070.9 3979
100mW
continuous
3 32 (5min) 50 (15min) 25 (15min) 60 (45min) 3.370.2 2.970.3 (12%) 3.970.4 3775
100mW
continuous
24 20 (10min) 58 (35min) 60 (5min) 66 (10min) 4.370.1 3.570.2 (19%) 3.670.9 38710
25mW
continuous
24 0 (20min) 43 (45min) 57 (25min) 70 (40min) 3.570.2 2.670.2 (26%) 4.970.4 6077
100mW
fractionated
(5 10J)
24 46 (15min) 60 (25min) No change No change 4.170.1 3.870.1 (7%) 4.670.7 5379
The minimum HbSat values reached and the maximum values attained during recovery are shown, each with the time from switching on the laser at which these were
documented. The 40min post-PDT fluorescein exclusion data includes the percentage reduction compared with the 2min post-PDT value. Owing to the way the liver lobe was
arranged during PDT, the zone of necrosis was elliptical rather than circular. All oxygen measurements were made along the axis where the extent of necrosis was known to be
the greatest, so the area of necrosis tabulated here is less than the area corresponding to a circle of the radius documented in the previous column. The zones of fluorescein
exclusion were essentially circular.
Figure 4 Fluorescein fluorescence image taken 2min after PDT with a
DLI of 3h and continuous illumination at 100mW. White scale bar¼1cm.
Dashed line shows boundary of fluorescein exclusion zone.
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and immediately after PDT with different light delivery regimens
were unexpected. The only animals in which significant HbSat
changes were detected 3.5mm from the laser fibre were those
treated with a short DLI (1 or 3h). Most likely, these changes were
due to vascular effects at a time when the blood level of
photosensitiser was high. However, surprisingly, the zone of
fluorescein exclusion immediately after light delivery was greater
for rats treated with the same light fluence rate (100mW
continuous), but a 24-h drug-light interval (Table 1). Reperfusion
was also greater in the 24-h group (correlating well with the
recovery in HbSat at 2.5mm), so the fluorescein exclusion zone
40min after light delivery was roughly the same in all three, and
was comparable to the final area of necrosis.
The other two light delivery regimens applied with a 24-h DLI,
that is, low power and fractionated delivery, both produced larger
zones of necrosis although different mechanisms may be
responsible. The generally accepted rationale for using low-power
illumination is that tissue oxygenation levels can be maintained
better throughout treatment. With light fractionation, the rationale
is that reoxygenation can occur during the dark interval (Foster
et al, 1991). Low-power illumination has been shown to enhance
PDT with several other photosensitisers such as mTHPC (Coutier
et al, 2002; Tsutsui et al, 2002), which was ascribed to lower rates
of oxygen consumption. In this study using low power (25mW),
the HbSat at 1.5mm fell at a slower rate during treatment
compared with the 100mW continuous regimen. At the 2.5mm
separation with low power, the HbSat fell to 0%, but recovered to
near pretreatment levels, corresponding to a large reperfusion
effect 40min after PDT, which suggests that under these conditions
the vascular effects at and outside the 2.5mm separation zone were
largely reversible (Table 1). Nevertheless, in this case, the final
zone of necrosis (radius 4.9mm) was considerably larger than the
40min fluorescein exclusion zone (radius 2.6mm). Reperfusion
injury seems likely to have made a much larger contribution here
than in the treatments undertaken at 100mW. The difference
between this and the 24h, 100mW treatment may be related to the
duration of ischaemia, which was more than half an hour here, but
less than 10min in the 100mW case (Table 1)
In the light fractionation study, there was only a small fall post-
treatment in HbSat at a 2.5mm separation between the fibres
(Figure 3E) and only a moderate fluorescein reperfusion effect
(Table 1). In this case, we conclude that the larger zone of necrosis
compared to continuous irradiation was probably due to the better
maintenance of oxygen levels during light delivery. Fractionated
irradiation has been shown to improve AlS4Pc PDT in a murine
tumour model (Anholt and Moan, 1992), although no oxygen
measurements were made in that study. Oxygen measurements
were made using a microelectrode during PDT with 5-aminolae-
vulinic acid using continuous or fractionated illumination in
the normal rat colon (Curnow et al, 2000). Two light fractions
were used, 5 and 20J separated by 150s, which resulted in
a larger area of necrosis compared to continuous irradiation and
this effect was ascribed to recovery of oxygen levels during the
dark interval.
In summary, using a combination of fluorescein angiography
with haemoglobin oxygen saturation monitoring, we have been
able to compare noninvasively the responses to PDT under
different light delivery regimens. During PDT, vascular shutdown
was observed which together with photochemical oxygen con-
sumption resulted in a significant decline in tissue haemoglobin
oxygen saturation levels, with the largest drop seen in areas that
received the highest light dose. Tissue reperfusion following PDT
monitored by fluorescein angiography contributed to the observed
reoxygenation. Oxygen back-diffusion from the surrounding
nonirradiated tissue and decreased metabolic consumption are
assumed to be other factors aiding reoxygenation. Comparing the
results of this study with previous work it is clearly apparent,
despite the differences in technique and experimental models, that
the relationship between tissue oxygenation levels measured
during and shortly after light delivery and the final extent of
PDT necrosis produced is critically dependent on the treatment
conditions. From our observations in normal liver, it would appear
that if there is any fall in HbSat, then tissue at that point will be
necrosed, but clearly in some cases, as with the low-power
illumination (25mW), the necrosis extends well beyond the point
furthest from the laser fibre at which any drop in HbSat is
detected. It would be attractive to speculate that if the optimal light
delivery conditions (appropriate power and energy level, with or
without fractionation) could be predicted from real-time oxygen
monitoring, the efficacy of PDT could be improved, although the
more data that become available, the more complex the analysis
becomes.
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